ULTRAGENYX PHARMACEUTICAL INC. (RARE)
Clinical trial NCT05345171 updates: 1. enrollment: 32 → 37 participants 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05345171 updates: 1. enrollment: 32 → 37 participants 2. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical